Primary Site >> Pancreatic Cancer

Gene >> PHB

Journal: Gan To Kagaku Ryoho. 2008 Nov;35(12):2120-2.
Title: [S-1+gemcitabine (GEM) therapy was effective in a case of unresectable pancreatic head carcinoma].
Author: Takada, Joji|Okuda, Kouji|Kenno, Sachiko|Shimada, Shingo|Oba, Go|Shimokuni, Tatsushi|Aoki, Takanori|Hamada, Hiromi
PMID: 19106543
Journal: Zhonghua Wai Ke Za Zhi. 2012 Mar;50(3):260-3.
Title: [Validation of candidate immunogenic membrane antigens of human pancreatic cancer screened by proteomics].
Author: Wang, Wei-bin|Zhao, Yu-pei|Liao, Quan|Zhang, Tai-ping|Xu, Lai|Wu, Yuan-de
PMID: 22800753
Journal: Mol Cancer. 2014 Feb 25;13:38.
Title: Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma.
Author: Luan, Zhou|He, Ying|Alattar, Mohamed|Chen, Zhishui|He, Fan
PMID: 24568222
Journal: Tumour Biol. 2015 Feb;36(2):1221-31.
Title: Identification of prohibitin 1 as a potential prognostic biomarker in human pancreatic carcinoma using modified aqueous two-phase partition system combined with 2D-MALDI-TOF-TOF-MS/MS.
Author: Zhong, Ning|Cui, Yazhou|Zhou, Xiaoyan|Li, Tianliang|Han, Jinxiang
PMID: 25344214
Journal: Oncotarget. 2016 Dec 13;7(50):83641-83656.
Title: Bisdemethoxycurcumin exerts pro-apoptotic effects in human pancreatic adenocarcinoma cells through mitochondrial dysfunction and a GRP78-dependent pathway.
Author: Yang, Haopeng|Fan, Shengjun|An, Yu|Wang, Xin|Pan, Yan|Xiaokaiti, Yilixiati|Duan, Jianhui|Li, Xin|Tie, Lu|Ye, Min|Li, Xuejun
PMID: 27845899
Journal: Clin Transl Gastroenterol. 2018 Sep 6;9(9):178.
Title: A novel prognostic marker and immunogenic membrane antigen: prohibitin (PHB) in pancreatic cancer.
Author: Wang, Weibin|Xu, Lai|Yang, Yu|Dong, LiangBo|Zhao, BangBo|Lu, Jun|Zhang, Taiping|Zhao, Yupei
PMID: 30185797